| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.33 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |